Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Testosterone Undecanoate Extension Study
NCT01699178Phase 3Completed
- Sponsor
- Clarus Therapeutics
- Start
- Aug 2012
- Primary completion
- Apr 2014
- Modality
- Hormone, Biologic
- Countries
- 2
01
Overview
A Phase 3 trial of testosterone undecanoate in male hypogonadism, sponsored by Clarus Therapeutics. Started Aug 2012; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
male hypogonadism
Beyond the preview
Go deeper on NCT01699178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01699178.